Summit Chemical · SMCH
DEMO DATAUNDERWRITING ASSUMPTIONPASSDebt schedule & capital structure — FY2025A (2026-03-31)
DEMO DATA| Facility | Rank | Sec. | Face value | Rate type | Coupon / spread | Floor | PIK | All-in (base, 1st period) | Annual interest | Maturity | Amort. | Cum. leverage | Mark / price | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revolver (commit $400M) | 1 | Secured | $100.0M | Floating | S+265bp | — | — | 6.90% | $6.9M | 2027-12-31 | bullet | 0.3x | — | |
| First-Lien Term Loan | 1 | Secured | $900.0M | Floating | S+385bp | — | — | 8.10% | $72.9M | 2028-03-31 | 1.0%/yr | 2.6x | 97.0 | |
| Senior Unsecured Notes 5.75%TARGET | 3 | Unsecured | $750.0M | Fixed | 5.75% | — | — | 5.75% | $43.1M | 2028-10-15 | bullet | 4.5x | 92.0UNDERWRITING ASSUMPTION | |
| Total debt (face value) | $1.8B | $122.9M | 4.5x | |||||||||||
| Less: cash | ($120.0M) | |||||||||||||
| Net debt | $1.6B | 4.2x | ||||||||||||
| Equity (residual: EV − net debt, EV at assumed multiple) | $1.1B | Goes to zero in any scenario where recovery value < claims. | ||||||||||||
Face value = legal claim; purchase price / mark is what an investor pays; coupon is the contractual cash / PIK return; yield and recovery are derived on the Returns and Recovery tabs. Illustrative appraised / collateral value (DEMO)
Maturity wall & refinancing requirement
| Period | Debt due | % of debt | Projected liquidity | Refi requirement | Liq. ÷ maturity | Risk |
|---|---|---|---|---|---|---|
| FY2027E | $100M | 6% | $405M | — | 4.1x | Low |
| FY2028E | $1.6B | 94% | $400M | $1.3B | 0.2x | High |
Projected liquidity = cash + undrawn revolver entering the period + that period’s positive FCF, in the selected scenario. * Beyond the 5-period horizon; liquidity shown at the end of period 5. Maturity periods map actual maturity dates to the model’s period-end month (December).
Refinancing risk engine — Severe Downside
ANALYST PROJECTIONFor every maturing tranche: balance at maturity → can projected cash repay it? → if not, does leverage (net debt ÷ EBITDA ≤ scenario limit) and pro-forma interest coverage (≥ scenario minimum, at the assumed refinancing rate) permit refinancing? A failure with insufficient cash is a payment default and feeds the recovery waterfall.
| Tranche | Matures | Balance at maturity | Cash on hand | Net lev. (test ≤) | Pro-forma coverage (test ≥) | Refi rate | Interest burden after | Result | Resolution |
|---|---|---|---|---|---|---|---|---|---|
| Revolver | FY2027E | $0.0M | $5M | 17.5x (5.0x) | 0.67x (2.00x) | 13.5% | — | REFINANCING FAILURE | Repaid from cash |
| First-Lien Term Loan | FY2028E | $873.0M | ($98M) | 15.5x (5.0x) | 0.51x (2.00x) | 13.5% | — | REFINANCING FAILURE | Payment default |
| Senior Unsecured Notes 5.75% | FY2028E | $750.0M | ($98M) | 15.5x (5.0x) | 0.51x (2.00x) | 13.5% | — | REFINANCING FAILURE | Payment default |
Projected debt balances by tranche — Severe Downside
| Tranche | Current | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|---|
| Revolver | $100.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| First-Lien Term Loan | $900.0M | $891.0M | $882.0M | $873.0M | $864.0M | $855.0M |
| Senior Unsecured Notes 5.75% | $750.0M | $750.0M | $750.0M | $750.0M | $750.0M | $750.0M |
| Total debt | $1.8B | $1.6B | $1.6B | $1.6B | $1.6B | $1.6B |
| Cash | $120.0M | $5.1M | ($97.9M) | ($209.8M) | ($309.3M) | ($388.5M) |
| Cash interest | $122.9M | $152.9M | $139.8M | $136.6M | $135.7M | $134.7M |
| PIK interest (non-cash) | — | — | — | — | — | |
| Funding gap | — | $97.9M | $209.8M | $309.3M | $388.5M |
R = remainder refinanced at the scenario refinancing rate. Maturities are repaid from cash above the minimum-cash reserve first; the market-access test governs only the remainder.
Sources & data lineage (3)
| Source | Document | Data type | Period | Accession | Doc date | Retrieved | Class |
|---|---|---|---|---|---|---|---|
| CreditIQ demo dataset | Summit Chemical — illustrative financial statements FY2022–FY2025 | Income statement / cash flow | FY2022–FY2025 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |
| CreditIQ demo dataset | Summit Chemical — illustrative capital structure & covenants | Debt schedule | As of 2026-03-31 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |
| CreditIQ demo dataset | Illustrative indicative bid marks (% of par) | Market price | 2026-03-31 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |